Sesha umjovo ongcono kakhulu wokwenza isikhumba sibe mhlophe futhi ngokuvamile uzohlangana namagama amathathu afanayo: glutathione, vitamin C (ascorbic acid) kanye ne-tranexamic acid (TXA). Imitholampilo ivamise ukwethula 'izithombe ezikhanyayo' ezishintshashintshayo, nokho zisebenza ngezindlela ezihlukene, zilethwa ngezindlela ezihlukene futhi ziphethe amazinga ahlukene kakhulu obufakazi. Ngakho yikuphi okukhanyisa isikhumba kangcono? Impendulo eqotho incike enkingeni ye-pigment ephathwayo.
Kulesi sihloko, 'ukukhanya' kusho ithoni yakusihlwa kanye nokufiphala kombala okweqile okufana ne-melasma, amabala elanga noma izimpawu zangemva kokuvuvukala. Akusho ukushintsha ibala lesikhumba lomuntu elingokwemvelo, elinqunywa izakhi zofuzo, futhi akukho nesisodwa salezi zithako esingakwenza lokho unomphela. Ngezansi uzothola ithebula lokuqhathanisa elihlangene, iphrofayili emfushane yesithako ngasinye, umhlahlandlela wesinqumo ngokukhathazeka kwesikhumba kanye namaphuzu abalulekile okuphepha nokulawula okufanele imitholampilo nabasabalalisi bakwazi.
I-Glutathione vs Vitamin C vs Tranexamic Acid: Ithebula Lokuqhathanisa
Isici |
I-Glutathione (GSH) |
Vitamin C (ascorbic acid) |
I-Tranexamic acid (TXA) |
Indlela eyinhloko |
I-antioxidant tripeptide; ivimbela i-tyrosinase ngokuqondile nangokungaqondile futhi iguqule ukukhiqizwa kwe-melanin isuke ku-eumelanin emnyama iye ku-phaeomelanin ekhanyayo |
I-Antioxidant; ivimbela i-tyrosinase ngokusebenzisana nethusi endaweni esebenzayo ye-enzyme, inciphisa ukwakheka kwe-melanin. |
I-Plasmin inhibitor; iphazamisa indlela ye-plasminogen-plasmin exhumanisa ukuchayeka kwe-UV namaseli esikhumba ekuvuselelweni kwe-melanocyte. |
Isetshenziswa kanjani |
Amaphilisi omlomo noma ama-lozenges, ama-creams ama-topical; Amadriphu e-IV adumile kodwa angekho ilebula; ngezinye izikhathi zengezwa kuma-cocktail we-mesotherapy we-intradermal |
ama-serums we-topical; I-intradermal mesotherapy noma i-microneedling ye-pigment; Imithamo ephezulu ye-IV infusions iwukusetshenziswa okuhlukile, okuhlelekile |
I-Intradermal microinjection noma i-mesotherapy ku-lesion, i-microneedling, i-topical, kanye ne-oral (incwadi kadokotela) |
Ifaneleka kakhulu |
Ubuthuntu obujwayelekile kanye nokwesekwa kwe-antioxidant, njengesengezo |
Ubuthuntu, ukulimala kwesithombe kanye ne-epidermal pigment emaphakathi; umlingani ojwayelekile ku-TXA |
I-Melasma kanye nenkani, i-hormone- noma i-UV-driven pigment yobuso |
Ikhwalithi yobufakazi |
Ama-RCT amancane omlomo kanye nama-topical abonisa ukuncishiswa kwe-melanin-inkomba enesizotha; ucwaningo olulodwa kuphela lwe-IV olulawulwa yi-placebo olubuthakathaka, olwalungabalulekile |
Izivivinyo ezincane kanye nokuhlaziywa kwe-meta ka-2024 kubonisa i-mesotherapy enevithamini C isebenza ngendlela efanayo ne-TXA mesotherapy ku-melasma. |
Okuqine kakhulu kokuthathu kwe-melasma, nakuba izifundo eziningi zokujova zisezincane futhi zifushane |
Amanothi okuphepha abalulekile |
IV ukusetshenziswa okuxhumene nesibindi, izinso kanye nokusabela kwesikhumba kuzixwayiso zomlawuli; akukho imithamo ye-IV evunyelwe yokukhanyisa isikhumba |
Ukusetshenziswa kwe-Intradermal kungaluma noma kushise; ukusetshenziswa kwedosi ephezulu IV kuthwala izinkinga zezinso kanye nokuntuleka kwe-G6PD |
Ububomvu bendawo, ukulimaza nokungakhululeki; ukuhlolwa kwengozi yokujiya kuwumkhuba ojwayelekile ngaphambi kokusetshenziswa okuhleliwe |
Izinhlanganisela ezijwayelekile |
Kwengezwe kuma-cocktails e-TXA + vitamin C |
Imataniswe ne-TXA, ene-glutathione noma ngaphandle kwayo |
Isithako esiyisisekelo sama-cocktail amaningi e-melasma |
I-Glutathione: Idumile, kodwa Ubufakazi Buncane
I-Glutathione iyi-antioxidant yemvelo etholakala cishe kuwo wonke amaseli. Izibuyekezo zichaza umphumela wayo wokukhanya njengokuvela ekuvinjweni okuqondile nokungaqondile kwe-tyrosinase nasekushintsheni ukwakheka kwe-melanin kuya kumbala okhanyayo (Sonthalia et al., 2016). Ezifundweni ezilawulwayo, nokho, umphumela unesizotha. Uhlolo olungahleliwe, oluyimpumputhe kabili kumavolontiya e-Thai angama-60 luthole ukuthi i-500 mg ye-glutathione yomlomo nsuku zonke amasonto amane yehlise izinkomba ze-melanin ngaphezu kwe-placebo ezindaweni ezimbili kuphela kweziyisithupha (i-Arjinpathana ne-Asawanonda). Ucwaningo olunelebula evulekile lwe-buccal lozenge kwabesifazane basePhilippines abangama-30 luphinde lwabika izinkomba ze-melanin eziwayo, kodwa lalingenalo iqembu le-placebo (Handog et al., 2016).
Ubufakazi be-glutathione efakwa emthanjeni bubuthakathaka namanje. Ucwaningo lwe-IV olulawulwa yi-placebo kuphela alutholanga umehluko omkhulu kusuka ku-saline (37.5% vs 18.7% ithuthukisiwe, p = 0.054), ukuthuthukiswa kwaphela phakathi nezinyanga eziyisithupha, futhi abahlanganyeli abaningana babe nokuhlolwa okungavamile kwesibindi noma i-anaphylaxis (Zubair et al., 2016). Ukubuyekezwa okuhlelekile kwango-2024 kuphethe ngokuthi i-IV glutathione ayivunyelwe ukukhanyisa isikhumba nokuthi i-glutathione 'ingasebenza kakhulu njenge-antioxidant ku-melasma' (Sarkar et al.). Ukuze uthole isizinda esinobungane nesineke, bheka yethu umhlahlandlela wokuthi imijovo ye-glutathione emhlophe yesikhumba isebenza kanjani.
I-Vitamin C: I-Antioxidant Partner
I-Ascorbic acid inciphisa ama-radicals mahhala akhiqizwa ukukhanya kwe-UV futhi ivimbele i-tyrosinase, yingakho kudala isetshenziselwa ukuguga kwezithombe kanye ne-hyperpigmentation (Telang, 2013). Ubuthakathaka bayo obuyinhloko ukulethwa: i-vitamin C ayizinzile futhi inzima ukungena ku-dermis ekugxilweni okuwusizo, okuchaza isithakazelo ku-mesotherapy kanye ne-microneedling.
Lapho uvithamini C ejovwa nge-intradermally ye-melasma, ibamba eyakhe. Ukuhlaziywa kwemeta ka-2024 kwezifundo ezinhlanu (iziguli eziyi-127) akutholanga mehluko obalulekile ngokwezibalo ekuthuthukisweni kwe-MASI phakathi kwe-TXA mesotherapy kanye ne-vitamin C mesotherapy futhi kwagwetshwa zombili njengeziphephile (Liao et al.). Izifundo bezizincane, ngakho-ke lokhu kufundwa kangcono njengokuthi 'okuqhathaniswa ngaphakathi kwedatha elinganiselwe' kunobufakazi bokulingana.
I-Tranexamic Acid: Uchwepheshe we-Melasma
I-Tranexamic acid yasungulwa njengomuthi wokunciphisa ukopha. Iqhaza layo ku-pigment livela ekuvimbeni umsebenzi we-plasmin, umzila ohilelekile ekusebenziseni i-UV-icuphe i-melanocyte. Esifundweni sokuqala se-intradermal, abesifazane baseKorea be-85 bathola ama-microinjections e-4 mg / mL masonto onke ezilonda ze-melasma amasonto angu-12; isilinganiso sesilinganiso se-MASI sehle sisuka ku-13.22 saya ku-7.57 sinemiphumela emibi emincane (Lee et al., 2006). Lolo cwaningo lwalungenalo iqembu lokulawula. Ukuhlolwa okungahleliwe kwakamuva ezigulini ezingama-60 kwathola ukuthuthukiswa kwe-MASI okungama-35.72% ngama-microinjections e-TXA kanye nama-44.41% ane-TXA alethwa yi-microneedling, ngaphandle kwezehlakalo ezinkulu ezimbi (Budamakuntla et al., 2013).
Imininingwane yephrothokholi, izikhawu zeseshini nokukhethwa kwesiguli kufakwe esihlokweni sethu esizinikezele sokuthi i-tranexamic acid mesotherapy ye-melasma , ngakho-ke ngeke siziphinde lapha.
Ikuphi Okungcono Kakhulu? Umhlahlandlela Wesinqumo Ngokukhathazeka Kwesikhumba
Awukho umjovo owodwa ongcono kakhulu wokwenza ube mhlophe. Ukukhetha okulungile kulandela ukuxilongwa:
I-Melasma
I-TXA iyisithako sokuqala odokotela besikhumba abaningi abasifinyelelayo, silethwe nge-intradermally noma nge-microneedling, eduze nokuvikelwa kwelanga okuqinile. I-Vitamin C mesotherapy iyindlela ehlukile noma uzakwethu onengqondo, uma kubhekwa imiphumela eqhathanisekayo ekuhlaziyweni kwemeta. I-Glutathione isengezo ozikhethela sona, hhayi impendulo ezimele yodwa.
Ubuthuntu sekukonke kanye nephimbo elingalingani
Esikhumbeni esikhathele, esithambile noma esilimele isithombe ngaphandle kokuphazamiseka kwe-pigment echaziwe, ukwesekwa kwe-antioxidant kubaluleke kakhulu. I-Vitamin C iwumgogodla onengqondo, futhi i-glutathione ingase ibe nomthelela ekuzuzeni i-antioxidant. Okulindelekile kufanele kufakwe 'njengesikhumba esisha, esilinganayo', hhayi ibala elikhanyayo.
I-post-inflammatory hyperpigmentation (PIH)
Amamaki ashiywe ngemva kwezinduna noma ukucasuka ngokuvamile ayashabalala ngokuhamba kwesikhathi, ukuvikeleka elangeni nokunakekelwa okuthambile kwezihloko. Uma kusetshenziswa imijovo, izivumelwano zokucasuka kancane ezinovithamini C noma i-TXA zinengqondo, ngoba ukwelashwa okunolaka kungabangela umbala omusha. Uhlolojikelele lwethu lwe imijovo ekhanyisa isikhumba ye-hyperpigmentation ichaza izinhlobo ze-pigment eziyinhloko ngokuningiliziwe.
Ukwesekwa kwe-Antioxidant ezungeze ezinye izinqubo
Uvithamini C kanye ne-glutathione kuvame ukukhethwa njengezithako ezisekelayo ezizungeze ama-lasers noma ama-peels. Azifaki esikhundleni sohlelo lokwelapha oluqondene ne-pigment.
Ngenxa yokuthi izithako ezintathu zisebenza ezinyathelweni ezihlukene zokwakheka kombala, amafomula akhanyayo esimanje ngokuvamile ahlanganisa i-TXA, i-vitamin C ne-glutathione esikhundleni sokukhetha eyodwa. Idatha yomtholampilo isekela lo mqondo, okungenani ezivivinyweni ezincane. Esivivinyweni esiyimpumputhe esiphindwe kabili, sobuso obuhlukanisiwe beziguli ze-melasma ze-24, i-TXA kanye ne-ascorbic acid yehlise amaphuzu e-MASI ngaphezu kwe-TXA kanye ne-placebo emavikini e-8 ne-12, nakuba ubuhlungu obuvuthayo babubonakala kakhulu ohlangothini lwenhlanganisela (Pazyar et al., 2022). Kwesinye isilingo sobuso obuhlukene beziguli ezingama-30, i-cocktail ye-TXA 4 mg/mL, i-vitamin C 3% ne-glutathione 2% yehlise i-mMASI ngaphezu kwe-TXA ne-vitamin C kuphela, ngamanani afanayo obubomvu, ukuvuvukala kanye nemihuzuko (Iraji et al., 2019).
Ukuze uthole isingeniso esibanzi sokuthi le mikhiqizo ibekwe kanjani, funda yethu umhlahlandlela wokujova mhlophe kanye nokukhanya kwesikhumba.
Ukuphepha kanye Nomthetho
I-IV glutathione ayiwona umuthi ovunyelwe ukwenza mhlophe isikhumba ezimakethe eziningi. Eselulekweni sayo sango-2019, iPhilippine FDA ithe ibingakagunyazi noma yimuphi umkhiqizo ojovayo wokukhanyisa isikhumba, ivumele i-glutathione ejovayo kuphela njengesengezo ku-cisplatin chemotherapy, futhi yaxwayisa ngemiphumela yesibindi, izinso kanye nesistimu yezinzwa kanye nesifo sikaStevens-Johnson.
I-IV ye-vitamin C ephezulu ithwala izingozi zayo. Iseluleko esifanayo saphawula ukuthi imijovo kavithamini C ingase yakhe amatshe ezinso nokuthi imithamo emikhulu iholele ku-hemodialysis kubantu abanokuntuleka kwe-G6PD.
Imijovo yasendaweni ayinabungozi. Lindela ububomvu besikhashana, ukuluma, ukuvuvukala noma imihuzuko. Isu eliyinyumba nokujula okulungile kubalulekile.
Imiphumela ayiyona unomphela. I-pigment iyabuya uma ukuchayeka kwe-UV, amahomoni noma ukuvuvukala kuqhubeka. Ukuvikelwa kwelanga kwansuku zonke okubanzi kuyingxenye yayo yonke iphrothokholi.
Yazi imithetho yangakini. Ukubhaliswa komkhiqizo nokuthi ubani ongajova kuyehluka ngezwe. Ukwelashwa kufanele kunqunywe futhi kunikezwe odokotela abaqeqeshiwe.
Okwemitholampilo kanye Nabasabalalisi
Imitholampilo ibona imiphumela engcono kanye nezikhalazo ezimbalwa lapho ihlonza uhlobo lwe-pigment kuqala, ikhethe izinqubo ezisekelwe ku-TXA ze-melasma futhi yethule i-glutathione ngokwethembeka njengesijobelelo se-antioxidant esikhundleni sokushintsha umbala wesikhumba. Abasabalalisi kufanele bahlole ukuthi ukubhaliswa kwawo wonke umkhiqizo kanye nokulebula kuyahambisana nemakethe abaqondiswe kuyo.
I-AOMA ikhiqiza izixazululo ezikhanyayo ze-mesotherapy, okuhlanganisa i-TXA, ivithamini C kanye namafomula ayinhlanganisela, yokunikezwa kwesitoko kanye ne-OEM. Ungakwazi upheqa Ibanga lomjovo wokwenza mhlophe kwesikhumba kwe-AOMA . I-MOQ iqala kumayunithi angama-200 kuwo womabili ama-oda esitoko nawe-OEM. Ama-oda esitoko athunyelwa emahoreni angama-24, futhi isikhathi sokuhola se-OEM singamaviki angu-2–3 ngemva kokuqinisekiswa komsebenzi wobuciko, ifomula nemininingwane yokupakisha. I-AOMA iphethe izitifiketi ze-CE, ISO 13485, GMP kanye ne-FDA.
FAQ
Imuphi umjovo wokwenza mhlophe ongcono kakhulu?
Akekho noyedwa owinile. Nge-melasma, i-tranexamic acid inedatha yomjovo esekela kakhulu. Ukuze kube buthuntu okuvamile, i-vitamin C iyinketho enengqondo ye-antioxidant. I-Glutathione ngokuyinhloko iyisengezo. Udokotela kufanele ahlole inkinga ye-pigment ngaphambi kokukhetha.
Ingabe i-glutathione ingcono kunovithamini C wokukhanyisa isikhumba?
Hhayi ngokucacile. Zombili zinobufakazi obuncane, besikhathi esifushane kuphela. I-Vitamin C inedatha eminingi yomjovo we-melasma, kuyilapho i-IV glutathione yehlulekile ukushaya i-placebo esivivinyweni sayo esilawulwayo kuphela.
Ingabe i-tranexamic acid, uvithamini C ne-glutathione zingajovwa ndawonye?
Yebo, ama-cocktails ahlanganisiwe avamile, futhi izivivinyo ezincane zobuso obuhlukanisiwe zathola ukuthi ukwengeza uvithamini C, bese kuba yi-glutathione, ku-TXA kuthuthukise izikolo ze-melasma. Ukushiswa noma ukuluma kungase kwande ngenhlanganisela.
Ingabe imijovo yokwenza mhlophe iwushintsha unomphela umbala wesikhumba?
Cha. Angakwazi ukufiphalisa umbala owedlulele ngisho nethoni engaphandle, kodwa awawushintshi umbala wesikhumba wemvelo, futhi imiphumela iyanyamalala ngaphandle kokuvikelwa nokulondolozwa kwelanga.
Ingabe i-IV glutathione iphephile ekwenzeni mhlophe kwesikhumba?
Abalawuli abafana nePhilippine FDA baxwayise ngakho, futhi ukubuyekezwa okuhlelekile kwango-2024 kucatshangelwe ukuthi i-IV glutathione iphikisana nokukhanyisa isikhumba ngenxa yokuntuleka kokusebenza kahle nemiphumela engemihle.
Izithenjwa
Lee JH, Park JG, Lim SH, et al. I-intradermal microinjection yendawo ye-tranexamic acid yokwelashwa kwe-melasma ezigulini zase-Asia: isilingo sokuqala somtholampilo. I-Dermatol Surg . 2006;32(5):626–631. I-PMID: 16706756.
Budamakuntla L, Loganathan E, Suresh DH, et al. Ucwaningo olungahleliwe, oluvulekile, oluqhathaniswayo lwe-tranexamic acid microinjections kanye ne-tranexamic acid ene-microneedling ezigulini ezine-melasma. J Cutan Aesthet Surg . 2013;6(3):139–143. PMID: 24163529.
U-Liao X, u-Cheng F, u-Jiang Y. Ukusebenza nokuphepha kwe-mesotherapy nge-tranexamic acid ngokumelene ne-vitamin C ekwelapheni i-melasma: ukuhlaziywa kwe-meta nokubuyekezwa kwesistimu. J Cosmet Dermatol . 2024;23(9):2785–2792. PMID: 38693699.
Pazyar N, Molavi SN, Hosseinpour P, et al. Ukusebenza komjovo we-intradermal we-tranexamic acid ne-ascorbic acid ngokumelene ne-tranexamic acid ne-placebo ekwelapheni i-melasma: isilingo sokuqhathanisa sobuso obuhlukene. I-Health Sci Rep . 2022;5(2):e537. PMID: 35284654.
Iraji F, Nasimi M, Asilian A, et al. Ukusebenza kwe-mesotherapy nge-tranexamic acid ne-ascorbic acid ene-glutathione nangaphandle kwayo ekwelapheni i-melasma: isilingo sokuqhathanisa sobuso obuhlukene. J Cosmet Dermatol . 2019;18(5):1416–1421. I-PMID: 30735611.
I-Sonthalia S, i-Daulatabad D, i-Sarkar R. Glutathione njenge-ejenti emhlophe yesikhumba: amaqiniso, izinganekwane, ubufakazi kanye nezingxabano. I-Indian J Dermatol Venereol Leprol . 2016;82(3):262–272. PMID: 27088927.
USarkar R, Yadav V, Yadav T, et al. I-Glutathione njenge-ejenti ekhanyisa isikhumba kanye ne-melasma: ukubuyekezwa okuhlelekile. I-Int J Dermatol . 2025;64(6):992–1004 (ku-inthanethi 2024). PMID: 39444151.
U-Arjinpathana N, u-Asawanonda P. Glutathione njenge-ejenti emhlophe yomlomo: isifundo esilawulwa ngokungahleliwe, esingaboni kabili, esilawulwa yi-placebo. Ukwelashwa kwe-J Dermatolog . 2012;23(2):97–102. PMID: 20524875.
I-Handog EB, i-Datuin MS, i-Singzon IA. Ilebula evulekile, isilingo sengalo eyodwa yokuphepha nokusebenza kwenoveli yokulungiswa kwe-glutathione njenge-ejenti ekhanyisa isikhumba kwabesifazane base-Filipino. I-Int J Dermatol . 2016;55(2):153–157. PMID: 26148180.
Zubair S, Hafeez S, Mujtaba G. Ukusebenza kwe-glutathione emthanjeni uma kuqhathaniswa ne-placebo yokukhanyisa ithoni yesikhumba. J Pak Assoc Dermatol . 2016;26(3):177. https://jpad.com.pk/index.php/jpad/article/view/18
Thenga PS. I-Vitamin C ku-dermatology. I-Indian Dermatol Online J. 2013;4(2):143–146. PMID: 23741676.
Ukuphatha Ukudla Nezidakamizwa ePhilippines. I-FDA Advisory No. 2019-182: Ukusetshenziswa okungaphephile kwe-glutathione njenge-ejenti ekhanyisa isikhumba. 2019. https://www.fda.gov.ph/fda-advisory-no-2019-182-unsafe-use-of-glutathione-as-skin-lightening-agent/
Lesi sihloko senzelwe izinjongo zemfundo kuphela futhi akusona iseluleko sezokwelapha. Ukwelashwa okukhanyayo okujovayo kufanele kuhlolwe futhi kwenziwe odokotela abaqeqeshiwe ngokuhambisana nemithetho yendawo.
